Novartis Neupogen Biosimilar: On Sale Now

Novartis' Zarxio -- the first U.S. biosimilar drug -- is on sale for 15% less than the original drug, Amgen's blockbuster, Neupogen.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news